4
Changes in Ownership
BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001144204-19-043047
Director sold 13,332 shares at $3.67 ($48,891)
- Director acquired 13,332 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ARBEL IRIT · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-28 | Exercise or conversion : show line 1 in the form | +6,666 | $2.25 | $14,999 | 162,499 | D |
| 2019-08-28 | Exercise or conversion : show line 2 in the form | +6,666 | $2.25 | $14,999 | 169,165 | D |
| 2019-08-28 | Sale : show line 3 in the form | −13,332 | $3.67 | $48,891 | 155,833 | D |
| Open-market sales · 13,332 sh · avg $3.67 · $48,891 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-08-28 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −6,666 | 0 | D |
| 2019-08-28 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −6,666 | 0 | D |
Loading xslF345X03/tv528639_4.xml…